Rotating night shift work and mammographic density

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 7, 2012, Pages 1028-1037

  Peplonska, Beata ^a   Bukowska, Agnieszka ^a   Sobala, Wojciech ^a   Reszka, Edyta ^a   Gromadzinska, Jolanta ^a   Wasowicz, Wojciech ^a   Lie, Jenny Anne ^b   Kjuus, Helge ^b   Ursin, Giske ^b,c  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; CREATININE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BREAST CANCER; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; COMPUTER ASSISTED RADIOGRAPHY; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL MAMMOGRAPHY; FEMALE; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MIDWIFE; NURSE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; ROTATING NIGHT SHIFT WORK; SEASON; SHIFT WORKER; SMOKING; URINALYSIS;

ADULT; BREAST; BREAST NEOPLASMS; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; MIDWIFERY; NURSING STAFF; QUESTIONNAIRES; RISK FACTORS; WORK SCHEDULE TOLERANCE;

EID: 84863577392     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0005     Document Type: Article

References (63)

1. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Volume 98, Painting, Firefighting and Shiftwork. Lyon, France, 2010.
2. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001;93:1563-8. (Pubitemid 32998486)
3. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology 2006;17:108-11.
4. Lie JA, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control 2006;17:39-44. (Pubitemid 43083668)
5. Lie JA, Kjuus H, Zienolddiny S, Haugen A, Stevens RG, Kjaerheim K. Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics. Am J Epidemiol 2011; 173:1272-9.
6. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-7. (Pubitemid 32006465)
7. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001;93:1557-62. (Pubitemid 32998485)
8. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996;7:197-204. (Pubitemid 26155458)
9. Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer. 2011 Aug 6. [Epub ahead of print].
10. O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, et al. Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 2006;164:358-66. (Pubitemid 44297344)
11. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007;33:336-43. (Pubitemid 350186761)
12. Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, et al. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 2010;171:953-9.
13. Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D, et al. Night work and breast cancer - results from the German GENICA study. Scand J Work Environ Health 2010;36:134-41.
14. Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005;16:254-8. (Pubitemid 40314419)
15. Stevens RG. Artificial lighting in the industrialized world: circadian disruption and breast cancer. Cancer Causes Control 2006;17:501-7.
16. Schernhammer ES, Schulmeister K. Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer 2004;90:941-3. (Pubitemid 38495808)
17. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008;100:898-905. (Pubitemid 351881952)
18. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2010;19:729-37.
19. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005;97:1084-7. (Pubitemid 41417926)
20. Schernhammer ES, Hankinson SE. Urinary melatonin levels and post-menopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev 2009;18:74-9.
21. Travis RC, Allen DS, Fentiman IS, Key TJ. Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 2004;96:475-82. (Pubitemid 38443651)
22. Cos S, Sanchez-Barcelo EJ. Melatonin and mammary pathological growth Front. Neuroendocrinol 2000;21:133-70. (Pubitemid 30228502)
23. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: nature's most versatile biological signal? FEBS J 2006;273:2813-38.
24. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc 2006;12:186-93. (Pubitemid 46017608)
25. McCormack VA, dos SS I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
26. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-95. (Pubitemid 36936159)
27. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. (Pubitemid 19144991)
28. Ursin G. [Mammographic density as indicator of breast cancer risk]. Tidsskr Nor Laegeforen 2003;123:3373-6.
29. Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, et al. The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 1998;7:43-7. (Pubitemid 28087141)
30. Breast Imaging Reporting and Data System (BI-RADS). Reston, VA: American College of Radiology; 1998.
31. Peplonska B, Bukowska A, Gromadzinska J, Sobala W, Reszka E, Lie JA, et al. Night shift work characteristics and 6-sulfatoxymelatonin (MT6s) in rotating night shift nurses and midwives. Occup Environ Med 2012;69:339-46.
32. Ferrari SLP, Cribari-Neto F. Beta regression for modelling rates and proportions. J Appl Stat 2004;31:799-815. (Pubitemid 39173835)
33. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974;19:716-23.
34. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Lippincott Williams and Wilkins, Philadelphia, 1998.
35. Brudnowska J, Peplonska B. [Night shift work and risk of cancer-a literature review]. Med Pr 2011;62:323-38.
36. Costa G, Haus E, Stevens R. Shift work and cancer - considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health 2010;36:163-79.
37. Erren TC, Pape HG, Reiter RJ, Piekarski C. Chronodisruption and cancer. Naturwissenschaften 2008;95:367-82.
38. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, et al. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol 2009;48:646-790.
39. Villeneuve S, Fevotte J, Anger A, Truong T, Lamkarkach F, Gaye O, et al. Breast cancer risk by occupation and industry: analysis of the CECILE study, a population-based case-control study in France. Am J Ind Med 2011;54:499-509.
40. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006;60:97-108.
41. Cos S, Martinez-Campa C, Mediavilla MD, Sanchez-Barcelo EJ. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 2005;38:136-42. (Pubitemid 40293239)
42. Cos S, Gonzalez A, Martinez-Campa C, Mediavilla MD, onso-Gonzalez C, Sanchez-Barcelo EJ. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006;30:118-28. (Pubitemid 43766230)
43. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res 2006;40: 116-24.
44. Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuro Endocrinol Lett 2002;23 Suppl 1:17-9. (Pubitemid 34495376)
45. Okatani Y, Morioka N, Wakatsuki A. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res 2000;28:111-8. (Pubitemid 30125176)
46. Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007;99: 1178-87. (Pubitemid 47233068)
47. Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, et al. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005;14:1411-7. (Pubitemid 40807339)
48. Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, et al. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Post-menopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol 2005;162:826-34. (Pubitemid 41541366)
49. Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, et al. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat 2008;108:57-67. (Pubitemid 351623237)
50. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11:1048-53. (Pubitemid 35192656)
51. Greendale GA, Huang MH, Ursin G, Ingles S, Stanczyk F, Crandall C, et al. Serum prolactin levels are positively associated with mammo-graphic density in postmenopausal women. Breast Cancer Res Treat 2007;105:337-46. (Pubitemid 47596443)
52. Walker K, Fletcher O, Johnson N, Coupland B, McCormack VA, Folkerd E, et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 2009;69:6490-9.
53. McCormack VA, Dowsett M, Folkerd E, Johnson N, Palles C, Coupland B, et al. Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro- Caribbean women. Breast Cancer Res 2009;11:R38.
54. Nagata C, Matsubara T, Hara T, Fujita H, Nagao Y, Yamamoto S, et al. Urinary 6-sulfatoxymelatonin andmammographic density in Japanese women. Cancer Epidemiol Biomarkers Prev 2007;16:2509-12. (Pubitemid 351196390)
55. Atkinson C, Warren R, Bingham SA, Day NE. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999;8: 863-6. (Pubitemid 29508720)
56. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, et al. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 2011;103:744-52.
57. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30-7. (Pubitemid 36124293)
58. Stuedal A, Ma H, Bjorndal H, Ursin G. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women. Climacteric 2009;12:248-58.
59. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
60. Hsing AW, Meyer TE, Niwa S, Quraishi SM, Chu LW. Measuring serum melatonin in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2010;19:932-7.
61. Graham C, Cook MR, Kavet R, Sastre A, Smith DK. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res 1998;24:230-8. (Pubitemid 28206444)
62. Arendt J. Melatonin. Clin Endocrinol (Oxf) 1988;29:205-29.
63. Brisson J, Berube S, Diorio C, Sinotte M, Pollak M, Masse B. Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin D. Cancer Epidemiol Biomarkers Prev 2007;16:929-33. (Pubitemid 46910094)